A new practical control guide for respiratory disease [DL1] [RP2] in cattle can help UK farmers avoid economic losses as a result of the disease, which is estimated to cost the UK cattle industry £80 million annually. 
Norbrook's Chemical Synthesis Division also provides a unique service of contract synthesis (contract manufacture) from gram through to full-scale production to GMP requirements, conducted by us, an independent company committed to the highest standards of quality, service, efficiency and innovation.
We are able to provide our clients with a full range of services such as process development from bench top to pilot plant scale, and validated technology transfer to full-scale bulk pharmaceutical manufacture. The strictest client confidentiality is assured throughout.
There are many benefits of using our services and facilities:
- Outsourcing of non-core activities
- Speed of response and flexibility
- No need for capital investment
- Access to specialised facilities and services
- Savings due to cost effectiveness
- No compromise on quality.
The Norbrook 'Quality Culture' has ensured that approval of its manufacturing operations by the world's most rigorous regulatory authorities, as well as auditors from the major global healthcare companies, is achieved on a regular basis. Norbrook also continuously invests in the environment, with a policy of "green means green", to secure its bright future through sustainable growth.
In the current climate of rationalisation and increasing demands on capital expenditure, Norbrook offers world class manufacturing facilities at very competitive costs and provides pharmaceutical companies with a low cost, high quality alternative to investment in their own facilities. It is therefore no wonder that Norbrook lists many of the world's largest pharmaceutical companies among its prestigious client base.
Norbrook are fully compliant in all Manufacturing and Production processes and are governed by many regulatory bodies including MHRA (Medicines & Healthcare Products Regulatory Agency), EDQM (European Directorate for the quality of Medicines & Healthcare and the U.S. FDA (U.S. Food and Drug Administration) who recently conducted an extensive Audit across our 3 manufacturing sites in Newry without listing any 483 citations which in itself is a tremendous achievement.
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region. Please see our terms and conditions for further information.
If you are a veterinary surgeon and would like additional information on any of our products please email firstname.lastname@example.org